Literature DB >> 19461260

Measuring change in everyday cognition: development and initial validation of the cognitive change checklist (3CL).

John A Schinka1, Lisa M Brown, Zoe Proctor-Weber.   

Abstract

OBJECTIVE: There is ample evidence to support an informant-based approach in screening efforts for the identification of cases of Mild Cognitive Impairment and early Alzheimer disease, but existing instruments are not maximally designed to capture recent changes in cognitive status of the types seen in these disorders. The authors describe the construction of a multiscale informant rating checklist (Cognitive Change Checklist; 3CL) designed to be sensitive to the earliest stages of cognitive decline associated with degenerative dementias.
DESIGN: Scale development, reliability, and validity study.
SETTING: Memory Disorder Clinics. PARTICIPANTS: Three hundred fifty-nine individuals are evaluated for a memory disorder.
RESULTS: The analyses resulted in a 28-item informant rating checklist of cognitive change that is composed of four nonoverlapping scales titled Memory, Executive, Language, and Remote Recall. Scale reliabilities were found to be well within guidelines to support their use in the clinical assessment of change in global cognition and specific cognitive domains. Substantive support for the validity of the checklist was obtained from correlational analyses that showed significant scale relationships with neurocognitive measures, from the finding of differences in scale scores among diagnostic groups that paralleled that of the neurocognitive measures, and from examination of the sensitivity of the scales in receiver operating characteristic analyses.
CONCLUSION: These findings provide support for the use of the checklist as a clinical tool to facilitate identification of cases of Mild Cognitive Impairment and early Alzheimer disease. Further examination of the diagnostic utility of the scale, and of its value in combination with cognitive screening measures, will also be required.

Entities:  

Mesh:

Year:  2009        PMID: 19461260     DOI: 10.1097/JGP.0b013e31819e2d6c

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   7.996


  5 in total

1.  The measurement of everyday cognition: development and validation of a short form of the Everyday Cognition scales.

Authors:  Sarah Tomaszewski Farias; Dan Mungas; Danielle J Harvey; Amanda Simmons; Bruce R Reed; Charles Decarli
Journal:  Alzheimers Dement       Date:  2011-11       Impact factor: 21.566

2.  The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.

Authors:  Brendan J Guercio; Nancy J Donovan; Catherine E Munro; Sarah L Aghjayan; Sarah E Wigman; Joseph J Locascio; Rebecca E Amariglio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  Cognitive change checklist: psychometric characteristics in community-dwelling older adults.

Authors:  John A Schinka; Diane C Robinson; Whitney L Mills; Lisa M Brown
Journal:  Am J Geriatr Psychiatry       Date:  2012-12       Impact factor: 4.105

4.  The cognitive change checklist (3CL): cross-validation of a measure of change in everyday cognition.

Authors:  John A Schinka; Ashok Raj; David A Loewenstein; Brent J Small; Ranjan Duara; Huntington Potter
Journal:  Int J Geriatr Psychiatry       Date:  2010-03       Impact factor: 3.485

5.  Assessment of cognition in early dementia.

Authors:  Nina B Silverberg; Laurie M Ryan; Maria C Carrillo; Reisa Sperling; Ronald C Petersen; Holly B Posner; Peter J Snyder; Robin Hilsabeck; Michela Gallagher; Jacob Raber; Albert Rizzo; Katherine Possin; Jonathan King; Jeffrey Kaye; Brian R Ott; Marilyn S Albert; Molly V Wagster; John A Schinka; C Munro Cullum; Sarah T Farias; David Balota; Stephen Rao; David Loewenstein; Andrew E Budson; Jason Brandt; Jennifer J Manly; Lisa Barnes; Adriana Strutt; Tamar H Gollan; Mary Ganguli; Debra Babcock; Irene Litvan; Joel H Kramer; Tanis J Ferman
Journal:  Alzheimers Dement       Date:  2011-05-01       Impact factor: 21.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.